Cutler Group LP Acurx Pharmaceuticals, Inc. Call Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Call Options
2 transactions
Others Institutions Holding ACXP
# of Institutions
37Shares Held
2.71MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$8.74 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$2.97 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$1.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$1.18 Million0.0% of portfolio
-
Morgan Stanley New York, NY106KShares$860,2280.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $93.6M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...